MedPath

UZPRUVO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

UZPRUVO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1231784005

Prescription Type

Uso Hospitalario

Authorization Date

Feb 26, 2025

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1231784005
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
Yes
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

USTEKINUMABActive
Quantity: 130 mg
Name: USTEKINUMAB

ATC CLASSIFICATION (3)

L04A
L04AC
L04AC05

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.